{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,2]],"date-time":"2026-06-02T02:22:05Z","timestamp":1780366925673,"version":"3.54.1"},"reference-count":87,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2015,9,1]],"date-time":"2015-09-01T00:00:00Z","timestamp":1441065600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Infection"],"published-print":{"date-parts":[[2016,6]]},"DOI":"10.1007\/s15010-015-0836-0","type":"journal-article","created":{"date-parts":[[2015,8,31]],"date-time":"2015-08-31T15:27:27Z","timestamp":1441034847000},"page":"273-281","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":18,"title":["Combination antibiotic therapy for the treatment of infective endocarditis due to enterococci"],"prefix":"10.1007","volume":"44","author":[{"given":"Sebastiano","family":"Leone","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Silvana","family":"Noviello","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Silvano","family":"Esposito","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2015,9,1]]},"reference":[{"key":"836_CR1","first-page":"269","volume":"5","author":"ME Thiercelin","year":"1899","unstructured":"Thiercelin ME. Sur un diplocoque saprophyte de l\u2019intestin susceptible de devenir pathogen. C R Soc Biol. 1899;5:269\u201371.","journal-title":"C R Soc Biol."},{"key":"836_CR2","doi-asserted-by":"crossref","first-page":"1140","DOI":"10.1111\/1469-0691.12166","volume":"19","author":"C Chirouze","year":"2013","unstructured":"Chirouze C, Athan E, Alla F, Chu VH, Ralph Corey G, Selton-Suty C, Erpelding ML, Miro JM, Olaison L, Hoen B, International Collaboration on Endocarditis Study Group. Enterococcal endocarditis in the beginning of the 21st century: analysis from the International Collaboration on Endocarditis-Prospective Cohort Study. Clin Microbiol Infect. 2013;19:1140\u20137.","journal-title":"Clin Microbiol Infect"},{"key":"836_CR3","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1001\/archinternmed.2008.603","volume":"169","author":"DR Murdoch","year":"2009","unstructured":"Murdoch DR, Corey GR, Hoen B, Mir\u00f3 JM, Fowler VG Jr, Bayer AS, Karchmer AW, Olaison L, Pappas PA, Moreillon P, Chambers ST, Chu VH, Falc\u00f3 V, Holland DJ, Jones P, Klein JL, Raymond NJ, Read KM, Tripodi MF, Utili R, Wang A, Woods CW, Cabell CH, International Collaboration on Endocarditis-Prospective Cohort Study (ICE-PCS) Investigators. Clinical presentation, etiology, and outcome of infective endocarditis in the 21st century: the International Collaboration on Endocarditis-Prospective Cohort Study. Arch Intern Med. 2009;169:463\u201373.","journal-title":"Arch Intern Med"},{"key":"836_CR4","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1007\/s15010-012-0285-y","volume":"40","author":"S Leone","year":"2012","unstructured":"Leone S, Ravasio V, Durante-Mangoni E, Crapis M, Carosi G, Scotton PG, Barzaghi N, Falcone M, Chinello P, Pasticci MB, Grossi P, Utili R, Viale P, Rizzi M, Suter F. Epidemiology, characteristics, and outcome of infective endocarditis in Italy: the Italian Study on Endocarditis. Epidemiology, characteristics, and outcome of infective endocarditis in Italy: the Italian Study on Endocarditis. Infection. 2012;40:527\u201335.","journal-title":"Infection"},{"key":"836_CR5","doi-asserted-by":"crossref","first-page":"1314","DOI":"10.1086\/425009","volume":"39","author":"RW Finberg","year":"2004","unstructured":"Finberg RW, Moellering RC, Tally FP, Craig WA, Pankey GA, Dellinger EP, West MA, Joshi M, Linden PK, Rolston KV, Rotschafer JC, Rybak MJ. The importance of bactericidal drugs: future directions in infectious disease. Clin Infect Dis. 2004;39:1314\u201320.","journal-title":"Clin Infect Dis"},{"key":"836_CR6","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1586\/14787210.6.5.637","volume":"6","author":"CA Arias","year":"2008","unstructured":"Arias CA, Murray BE. Emergence and management of drug-resistant enterococcal infections. Expert Rev Anti Infect Ther. 2008;6:637\u201355.","journal-title":"Expert Rev Anti Infect Ther."},{"key":"836_CR7","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1128\/CMR.3.1.46","volume":"3","author":"BE Murray","year":"1990","unstructured":"Murray BE. The life and times of the Enterococcus. Clin Microbiol Rev. 1990;3:46\u201365.","journal-title":"Clin Microbiol Rev"},{"key":"836_CR8","doi-asserted-by":"crossref","first-page":"2580","DOI":"10.1172\/JCI106758","volume":"50","author":"RC Moellering Jr","year":"1971","unstructured":"Moellering RC Jr, Weinberg AN. Studies on antibiotic synergism against enterococci. II. Effect of various antibiotics on the uptake of 14 C-labeled streptomycin by enterococci. J Clin Invest. 1971;50:2580\u20134.","journal-title":"J Clin Invest."},{"key":"836_CR9","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1111\/j.1469-0691.2010.03214.x","volume":"16","author":"CA Arias","year":"2010","unstructured":"Arias CA, Contreras GA, Murray BE. Management of multidrug-resistant enterococcal infections. Clin Microbiol Infect. 2010;16:555\u201362.","journal-title":"Clin Microbiol Infect"},{"key":"836_CR10","doi-asserted-by":"crossref","first-page":"e394","DOI":"10.1161\/CIRCULATIONAHA.105.165564","volume":"111","author":"LM Baddour","year":"2005","unstructured":"Baddour LM, Wilson WR, Bayer AS, Fowler VG Jr, Bolger AF, Levison ME, Ferrieri P, Gerber MA, Tani LY, Gewitz MH, Tong DC, Steckelberg JM, Baltimore RS, Shulman ST, Burns JC, Falace DA, Newburger JW, Pallasch TJ, Takahashi M, Taubert KA, Committee on Rheumatic Fever, Endocarditis, and Kawasaki Disease, Council on Cardiovascular Disease in the Young, Councils on Clinical Cardiology, Stroke, and Cardiovascular Surgery and Anesthesia, American Heart Association, Infectious Diseases Society of America. Infective endocarditis: diagnosis, antimicrobial therapy, and management of complications: a statement for healthcare professionals from the Committee on Rheumatic Fever, Endocarditis, and Kawasaki Disease, Council on Cardiovascular Disease in the Young, and the Councils on Clinical Cardiology, Stroke, and Cardiovascular Surgery and Anesthesia, American Heart Association: endorsed by the Infectious Diseases Society of America. Circulation. 2005;111:e394\u2013434.","journal-title":"Circulation"},{"key":"836_CR11","doi-asserted-by":"crossref","first-page":"2369","DOI":"10.1093\/eurheartj\/ehp285","volume":"30","author":"G Habib","year":"2009","unstructured":"Habib G, Hoen B, Tornos P, Thuny F, Prendergast B, Vilacosta I, Moreillon P, de Jesus Antunes M, Thilen U, Lekakis J, Lengyel M, M\u00fcller L, Naber CK, Nihoyannopoulos P, Moritz A, Zamorano JL, ESC Committee for Practice Guidelines. Guidelines on the prevention, diagnosis, and treatment of infective endocarditis (new version 2009): the Task Force on the Prevention, Diagnosis, and Treatment of Infective Endocarditis of the European Society of Cardiology (ESC). Endorsed by the European Society of Clinical Microbiology and Infectious Diseases (ESCMID) and the International Society of Chemotherapy (ISC) for Infection and Cancer. Eur Heart J. 2009;30:2369\u2013413.","journal-title":"Eur Heart J"},{"key":"836_CR12","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1093\/jac\/dkr450","volume":"67","author":"FK Gould","year":"2012","unstructured":"Gould FK, Denning DW, Elliott TS, Foweraker J, Perry JD, Prendergast BD, Sandoe JA, Spry MJ, Watkin RW, Working Party of the British Society for Antimicrobial Chemotherapy. Guidelines for the diagnosis and antibiotic treatment of endocarditis in adults: a report of the Working Party of the British Society for Antimicrobial Chemotherapy. J Antimicrob Chemother. 2012;67:269\u201389.","journal-title":"J Antimicrob Chemother"},{"key":"836_CR13","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1086\/313949","volume":"31","author":"JW Chow","year":"2000","unstructured":"Chow JW. Aminoglycoside resistance in enterococci. Clin Infect Dis. 2000;31:586\u20139.","journal-title":"Clin Infect Dis"},{"key":"836_CR14","unstructured":"The European Committee on Antimicrobial Susceptibility Testing. Breakpoint tables for interpretation of MICs and zone diameters. Version 5.0, 2015. http:\/\/www.eucast.org . Accessed 27 July 2015."},{"key":"836_CR15","doi-asserted-by":"crossref","first-page":"2570","DOI":"10.1093\/jac\/dks277","volume":"67","author":"S Esposito","year":"2012","unstructured":"Esposito S, Esposito I, Leone S. Considerations of antibiotic therapy duration in community- and hospital-acquired bacterial infections. J Antimicrob Chemother. 2012;67:2570\u20135.","journal-title":"J Antimicrob Chemother"},{"key":"836_CR16","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/j.ijantimicag.2013.06.002","volume":"42","author":"S Leone","year":"2013","unstructured":"Leone S, Rossi M, Bisi L, Gori A, Esposito S. Antimicrobial therapy duration: a major matter in the management of severe infections. Int J Antimicrob Agents. 2013;42:287\u20138.","journal-title":"Int J Antimicrob Agents"},{"key":"836_CR17","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1086\/338233","volume":"34","author":"L Olaison","year":"2002","unstructured":"Olaison L, Schadewitz K. Enterococcal endocarditis in Sweden, 1995-1999: can shorter therapy with aminoglycosides be used? Clin Infect Dis. 2002;34:159\u201366.","journal-title":"Clin Infect Dis"},{"key":"836_CR18","doi-asserted-by":"crossref","first-page":"1810","DOI":"10.1161\/CIRCULATIONAHA.112.001170","volume":"127","author":"A Dahl","year":"2013","unstructured":"Dahl A, Rasmussen RV, Bundgaard H, Hassager C, Bruun LE, Lauridsen TK, Moser C, Sogaard P, Arpi M, Bruun NE. Enterococcus faecalis infective endocarditis: a pilot study of the relationship between duration of gentamicin treatment and outcome. Circulation. 2013;127:1810\u20137.","journal-title":"Circulation"},{"key":"836_CR19","doi-asserted-by":"crossref","first-page":"5033","DOI":"10.1016\/j.ijcard.2013.07.225","volume":"168","author":"M Bassetti","year":"2013","unstructured":"Bassetti M, Righi E, Crapis M, Cojutti P, Venturini S, Viale P, Pea F. Gentamicin once-daily in enterococcal endocarditis. Int J Cardiol. 2013;168:5033\u20134.","journal-title":"Int J Cardiol"},{"key":"836_CR20","doi-asserted-by":"crossref","first-page":"2954","DOI":"10.1128\/AAC.49.7.2954-2958.2005","volume":"49","author":"S Ono","year":"2005","unstructured":"Ono S, Muratani T, Matsumoto T. Mechanisms of resistance to imipenem and ampicillin in Enterococcus faecalis. Antimicrob Agents Chemother. 2005;49:2954\u20138.","journal-title":"Antimicrob Agents Chemother"},{"key":"836_CR21","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1128\/AAC.36.4.783","volume":"36","author":"I Klare","year":"1992","unstructured":"Klare I, Rodloff AC, Wagner J, Witte W, Hakenbeck R. Overproduction of a penicillin-binding protein is not the only mechanism of penicillin resistance in Enterococcus faecium. Antimicrob Agents Chemother. 1992;36:783\u20137.","journal-title":"Antimicrob Agents Chemother"},{"key":"836_CR22","doi-asserted-by":"crossref","first-page":"1980","DOI":"10.1128\/AAC.38.9.1980","volume":"38","author":"R Fontana","year":"1994","unstructured":"Fontana R, Aldegheri M, Ligozzi M, Lopez H, Sucari A, Satta G. Overproduction of a low-affinity penicillin-binding protein and high-level ampicillin resistance in Enterococcus faecium. Antimicrob Agents Chemother. 1994;38:1980\u20133.","journal-title":"Antimicrob Agents Chemother"},{"key":"836_CR23","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1128\/AAC.40.2.354","volume":"40","author":"M Ligozzi","year":"1996","unstructured":"Ligozzi M, Pittaluga F, Fontana R. Modification of penicillin-binding protein 5 associated with high-level ampicillin resistance in Enterococcus faecium. Antimicrob Agents Chemother. 1996;40:354\u20137.","journal-title":"Antimicrob Agents Chemother"},{"key":"836_CR24","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1093\/jac\/40.3.449","volume":"40","author":"M Venditti","year":"1997","unstructured":"Venditti M, Tarasi A, Capone A, Gali\u00e9 M, Menichetti F, Martino P, Serra P. Teicoplanin in the treatment of enterococcal endocarditis: clinical and microbiological study. J Antimicrob Chemother. 1997;40:449\u201352.","journal-title":"J Antimicrob Chemother"},{"key":"836_CR25","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1016\/j.ijantimicag.2004.06.004","volume":"24","author":"S Esposito","year":"2004","unstructured":"Esposito S, Noviello S, Leone S, Tice A, Seibold G, Nathwani D, Scaglione F, International OPAT Registry. Outpatient parenteral antibiotic therapy (OPAT) in different countries: a comparison. Int J Antimicrob Agents. 2004;24:473\u20138.","journal-title":"Int J Antimicrob Agents"},{"key":"836_CR26","first-page":"169","volume":"10","author":"S Esposito","year":"2002","unstructured":"Esposito S, Ianniello F, Noviello S, Leone S, Ascione T, Tice A, Maiello A, de Lalla F, Girmenia C, Marranconi F, Serrentino G, Iaccarino A, Di Cianni E. Outpatient Parenteral Antibiotic Therapy (OPAT): the Italian registry. Infez Med. 2002;10:169\u201375.","journal-title":"Infez Med."},{"key":"836_CR27","doi-asserted-by":"crossref","first-page":"1984","DOI":"10.1128\/AAC.39.9.1984","volume":"39","author":"JL Mainardi","year":"1995","unstructured":"Mainardi JL, Gutmann L, Acar JF, Goldstein FW. Synergistic effect of amoxicillin and cefotaxime against Enterococcus faecalis. Antimicrob Agents Chemother. 1995;39:1984\u20137.","journal-title":"Antimicrob Agents Chemother"},{"key":"836_CR28","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1128\/AAC.43.3.639","volume":"43","author":"J Gavald\u00e0","year":"1999","unstructured":"Gavald\u00e0 J, Torres C, Tenorio C, L\u00f3pez P, Zaragoza M, Capdevila JA, Almirante B, Ruiz F, Borrell N, Gomis X, Pigrau C, Baquero F, Pahissa A. Efficacy of ampicillin plus ceftriaxone in treatment of experimental endocarditis due to Enterococcus faecalis strains highly resistant to aminoglycosides. Antimicrob Agents Chemother. 1999;43:639\u201346.","journal-title":"Antimicrob Agents Chemother"},{"key":"836_CR29","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1093\/jac\/dkg360","volume":"52","author":"J Gavald\u00e1","year":"2003","unstructured":"Gavald\u00e1 J, Onrubia PL, G\u00f3mez MT, Gomis X, Ram\u00edrez JL, Len O, Rodr\u00edguez D, Crespo M, Ru\u00edz I, Pahissa A. Efficacy of ampicillin combined with ceftriaxone and gentamicin in the treatment of experimental endocarditis due to Enterococcus faecalis with no high-level resistance to aminoglycosides. J Antimicrob Chemother. 2003;52:514\u20137.","journal-title":"J Antimicrob Chemother"},{"key":"836_CR30","doi-asserted-by":"crossref","first-page":"574","DOI":"10.7326\/0003-4819-146-8-200704170-00008","volume":"146","author":"J Gavald\u00e0","year":"2007","unstructured":"Gavald\u00e0 J, Len O, Mir\u00f3 JM, Mu\u00f1oz P, Montejo M, Alarc\u00f3n A, de la Torre-Cisneros J, Pe\u00f1a C, Mart\u00ednez-Lacasa X, Sarria C, Bou G, Aguado JM, Navas E, Romeu J, Marco F, Torres C, Tornos P, Planes A, Falc\u00f3 V, Almirante B, Pahissa A. Brief communication: treatment of Enterococcus faecalis endocarditis with ampicillin plus ceftriaxone. Ann Intern Med. 2007;146:574\u20139.","journal-title":"Ann Intern Med"},{"key":"836_CR31","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.1093\/cid\/cit052","volume":"56","author":"N Fern\u00e1ndez-Hidalgo","year":"2013","unstructured":"Fern\u00e1ndez-Hidalgo N, Almirante B, Gavald\u00e0 J, Gurgui M, Pe\u00f1a C, de Alarc\u00f3n A, Ruiz J, Vilacosta I, Montejo M, Vallejo N, L\u00f3pez-Medrano F, Plata A, L\u00f3pez J, Hidalgo-Tenorio C, G\u00e1lvez J, S\u00e1ez C, Lomas JM, Falcone M, de la Torre J, Mart\u00ednez-Lacasa X, Pahissa A. Ampicillin plus ceftriaxone is as effective as ampicillin plus gentamicin for treating Enterococcus faecalis infective endocarditis. Clin Infect Dis. 2013;56:1261\u20138.","journal-title":"Clin Infect Dis"},{"key":"836_CR32","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.1111\/1469-0691.12756","volume":"20","author":"JM Pericas","year":"2014","unstructured":"Pericas JM, Cervera C, del Rio A, Moreno A, Garcia de la Maria C, Almela M, Falces C, Ninot S, Casta\u00f1eda X, Armero Y, Soy D, Gatell JM, Marco F, Mestres CA, Miro JM, Hospital Clinic Endocarditis Study Group. Changes in the treatment of Enterococcus faecalis infective endocarditis in Spain in the last 15\u00a0years: from ampicillin plus gentamicin to ampicillin plus ceftriaxone. Clin Microbiol Infect. 2014;20:1075\u201383.","journal-title":"Clin Microbiol Infect"},{"key":"836_CR33","doi-asserted-by":"crossref","first-page":"3028","DOI":"10.1128\/AAC.48.8.3028-3032.2004","volume":"48","author":"LB Rice","year":"2004","unstructured":"Rice LB, Bellais S, Carias LL, Hutton-Thomas R, Bonomo RA, Caspers P, Page MG, Gutmann L. Impact of specific pbp5 mutations on expression of beta-lactam resistance in Enterococcus faecium. Antimicrob Agents Chemother. 2004;48:3028\u201332.","journal-title":"Antimicrob Agents Chemother"},{"key":"836_CR34","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1093\/infdis\/173.4.909","volume":"173","author":"CM Brandt","year":"1996","unstructured":"Brandt CM, Rouse MS, Laue NW, Stratton CW, Wilson WR, Steckelberg JM. Effective treatment of multidrug-resistant enterococcal experimental endocarditis with combinations of cell wall-active agents. J Infect Dis. 1996;173:909\u201313.","journal-title":"J Infect Dis"},{"key":"836_CR35","doi-asserted-by":"crossref","first-page":"628","DOI":"10.3109\/00365549709035908","volume":"29","author":"SJ Antony","year":"1997","unstructured":"Antony SJ, Ladner J, Stratton CW, Raudales F, Dummer SJ. High-level aminoglycoside-resistant\u00a0Enterococcus\u00a0causing\u00a0endocarditis\u00a0successfully treated with a combination of ampicillin,\u00a0imipenem\u00a0and vancomycin. Scand J Infect Dis. 1997;29:628\u201330.","journal-title":"Scand J Infect Dis"},{"key":"836_CR36","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1128\/CMR.00030-13","volume":"26","author":"RM Humphries","year":"2013","unstructured":"Humphries RM, Pollett S, Sakoulas G. A current perspective on\u00a0daptomycin\u00a0for the clinical microbiologist. Clin Microbiol Rev. 2013;26:759\u201380.","journal-title":"Clin Microbiol Rev"},{"key":"836_CR37","first-page":"99","volume":"23","author":"S Leone","year":"2015","unstructured":"Leone S, Noviello S, Boccia G, De Caro F, Esposito S. Methicillin-resistant Staphylococcus aureus infections: role of daptomycin\/beta-lactams combination. Infez Med. 2015;23:99\u2013104.","journal-title":"Infez Med."},{"key":"836_CR38","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1016\/j.ijantimicag.2010.11.038","volume":"38","author":"C Cervera","year":"2011","unstructured":"Cervera C, Casta\u00f1eda X, Pericas JM, Del R\u00edo A, de la Maria CG, Mestres C, Falces C, Marco F, Moreno A, Mir\u00f3 JM. Clinical utility of daptomycin in infective\u00a0endocarditis\u00a0caused by Gram-positive cocci. Int J Antimicrob Agents. 2011;38:365\u201370.","journal-title":"Int J Antimicrob Agents"},{"key":"836_CR39","doi-asserted-by":"crossref","first-page":"6213","DOI":"10.1128\/AAC.01563-13","volume":"57","author":"M Carugati","year":"2013","unstructured":"Carugati M, Bayer AS, Mir\u00f3 JM, Park LP, Guimar\u00e3es AC, Skoutelis A, Fortes CQ, Durante-Mangoni E, Hannan MM, Nacinovich F, Fern\u00e1ndez-Hidalgo N, Grossi P, Tan RS, Holland T, Fowler VG Jr, Corey RG, Chu VH, International Collaboration on Endocarditis. High-dose\u00a0daptomycin\u00a0therapy for left-sided infective\u00a0endocarditis: a prospective study from the international collaboration on\u00a0endocarditis. Antimicrob Agents Chemother. 2013;57:6213\u201322.","journal-title":"Antimicrob Agents Chemother"},{"key":"836_CR40","doi-asserted-by":"crossref","first-page":"1669","DOI":"10.1093\/jac\/dku004","volume":"69","author":"I Cer\u00f3n","year":"2014","unstructured":"Cer\u00f3n I, Mu\u00f1oz P, Mar\u00edn M, Segado A, Roda J, Valerio M, Bouza E, Group for the Management of Infective Endocarditis of the Gregorio Mara\u00f1\u00f3n Hospital (GAME). Efficacy of\u00a0daptomycin\u00a0in the treatment of enterococcal\u00a0endocarditis: a 5 year comparison with conventional therapy. J Antimicrob Chemother. 2014;69:1669\u201374.","journal-title":"J Antimicrob Chemother"},{"key":"836_CR41","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1016\/j.ijantimicag.2014.08.002","volume":"44","author":"JM Munita","year":"2014","unstructured":"Munita JM, Murray BE, Arias CA. Daptomycin\u00a0for the\u00a0treatment\u00a0of\u00a0bacteraemia\u00a0due to\u00a0vancomycin-resistant enterococci. Int J Antimicrob Agents. 2014;44:387\u201395.","journal-title":"Int J Antimicrob Agents"},{"key":"836_CR42","doi-asserted-by":"crossref","first-page":"838","DOI":"10.1128\/AAC.05551-11","volume":"56","author":"G Sakoulas","year":"2012","unstructured":"Sakoulas G, Bayer AS, Pogliano J, Tsuji BT, Yang SJ, Mishra NN, Nizet V, Yeaman MR, Moise PA. Ampicillin\u00a0enhances daptomycin- and cationic host defense peptide-mediated killing of\u00a0ampicillin- and vancomycin-resistant Enterococcus faecium. Antimicrob Agents Chemother. 2012;56:838\u201344.","journal-title":"Antimicrob Agents Chemother"},{"key":"836_CR43","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1016\/j.ijantimicag.2009.12.022","volume":"35","author":"JM Entenza","year":"2010","unstructured":"Entenza JM, Giddey M, Vouillamoz J, Moreillon P. In vitro prevention of the emergence of daptomycin resistance in\u00a0Staphylococcus aureus\u00a0and enterococci following combination with amoxicillin\/clavulanic acid or ampicillin. Int J Antimicrob Agents. 2010;35:451\u20136.","journal-title":"Int J Antimicrob Agents"},{"key":"836_CR44","doi-asserted-by":"crossref","first-page":"2148","DOI":"10.1093\/jac\/dku113","volume":"69","author":"A Hall Snyder","year":"2014","unstructured":"Hall Snyder A, Werth BJ, Barber KE, Sakoulas G, Rybak MJ. Evaluation of the novel combination of daptomycin plus ceftriaxone against vancomycin-resistant enterococci in an in vitro pharmacokinetic\/pharmacodynamic simulated endocardial vegetation model. J Antimicrob Chemother. 2014;69:2148\u201354.","journal-title":"J Antimicrob Chemother"},{"key":"836_CR45","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1093\/jac\/dku381","volume":"70","author":"J Piszczek","year":"2015","unstructured":"Piszczek J, Hutchinson J, Partlow E. Failure of combination therapy with\u00a0daptomycin\u00a0and synergistic\u00a0ceftriaxone\u00a0for enterococcal endocarditis. J Antimicrob Chemother. 2015;70:623\u20134.","journal-title":"J Antimicrob Chemother"},{"key":"836_CR46","doi-asserted-by":"crossref","first-page":"4042","DOI":"10.1128\/AAC.02481-12","volume":"57","author":"G Sakoulas","year":"2013","unstructured":"Sakoulas G, Nonejuie P, Nizet V, Pogliano J, Crum-Cianflone N, Haddad F. Treatment of high-level gentamicin-resistant Enterococcus faecalis\u00a0endocarditis\u00a0with\u00a0daptomycin\u00a0plus ceftaroline. Antimicrob Agents Chemother. 2013;57:4042\u20135.","journal-title":"Antimicrob Agents Chemother"},{"key":"836_CR47","doi-asserted-by":"crossref","first-page":"1494","DOI":"10.1128\/AAC.02274-13","volume":"58","author":"G Sakoulas","year":"2014","unstructured":"Sakoulas G, Rose W, Nonejuie P, Olson J, Pogliano J, Humphries R, Nizet V. Ceftaroline\u00a0restores\u00a0daptomycin\u00a0activity against\u00a0daptomycin-nonsusceptible vancomycin-resistant Enterococcus faecium. Antimicrob Agents Chemother. 2014;58:1494\u2013500.","journal-title":"Antimicrob Agents Chemother"},{"key":"836_CR48","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1093\/jac\/dku386","volume":"70","author":"BJ Werth","year":"2015","unstructured":"Werth BJ, Barber KE, Tran KN, Nonejuie P, Sakoulas G, Pogliano J, Rybak MJ. Ceftobiprole and\u00a0ampicillin\u00a0increase daptomycin susceptibility of daptomycin-susceptible and -resistant VRE. J Antimicrob Chemother. 2015;70:489\u201393.","journal-title":"J Antimicrob Chemother"},{"key":"836_CR49","doi-asserted-by":"crossref","first-page":"1738","DOI":"10.1093\/jac\/dkv007","volume":"70","author":"JR Smith","year":"2015","unstructured":"Smith JR, Barber KE, Raut A, Aboutaleb M, Sakoulas G, Rybak MJ. \u03b2-Lactam combinations with\u00a0daptomycin\u00a0provide synergy against vancomycin-resistant\u00a0Enterococcus faecalis and\u00a0Enterococcus\u00a0faecium. J Antimicrob Chemother. 2015;70:1738\u201343.","journal-title":"J Antimicrob Chemother"},{"key":"836_CR50","doi-asserted-by":"crossref","first-page":"2842","DOI":"10.1128\/AAC.00053-15","volume":"59","author":"JR Smith","year":"2015","unstructured":"Smith JR, Barber KE, Raut A, Rybak MJ. \u03b2-Lactams enhance daptomycin activity against vancomycin-resistant Enterococcus faecalis and Enterococcus faecium in in vitro pharmacokinetic\/pharmacodynamic models. Antimicrob Agents Chemother. 2015;59:2842\u20138.","journal-title":"Antimicrob Agents Chemother"},{"key":"836_CR51","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1056\/NEJMoa053783","volume":"355","author":"VG Fowler Jr","year":"2006","unstructured":"Fowler VG Jr, Boucher HW, Corey GR, Abrutyn E, Karchmer AW, Rupp ME, Levine DP, Chambers HF, Tally FP, Vigliani GA, Cabell CH, Link AS, DeMeyer I, Filler SG, Zervos M, Cook P, Parsonnet J, Bernstein JM, Price CS, Forrest GN, F\u00e4tkenheuer G, Gareca M, Rehm SJ, Brodt HR, Tice A, Cosgrove SE, S. aureus Endocarditis and Bacteremia Study Group. Daptomycin\u00a0versus standard therapy for bacteremia and\u00a0endocarditis\u00a0caused by Staphylococcus aureus. N Engl J Med. 2006;355:653\u201365.","journal-title":"N Engl J Med"},{"key":"836_CR52","doi-asserted-by":"crossref","first-page":"3880","DOI":"10.1128\/AAC.00134-09","volume":"53","author":"KL LaPlante","year":"2009","unstructured":"LaPlante KL, Woodmansee S. Activities\u00a0of\u00a0daptomycin\u00a0and\u00a0vancomycin\u00a0alone\u00a0and in combination with rifampin and gentamicin against biofilm-forming methicillin-resistant Staphylococcus aureus isolates in an experimental model of endocarditis. Antimicrob Agents Chemother. 2009;53:3880\u20136.","journal-title":"Antimicrob Agents Chemother"},{"key":"836_CR53","doi-asserted-by":"crossref","first-page":"4172","DOI":"10.1128\/AAC.00051-09","volume":"53","author":"JM Mir\u00f3","year":"2009","unstructured":"Mir\u00f3 JM, Garc\u00eda-de-la-M\u00e0ria C, Armero Y, Soy D, Moreno A, del R\u00edo A, Almela M, Sarasa M, Mestres CA, Gatell JM, Jim\u00e9nez de Anta MT, Marco F, Hospital Clinic Experimental Endocarditis Study Group. Addition of gentamicin or rifampin does not enhance the effectiveness of daptomycin in treatment of experimental endocarditis due to methicillin-resistant Staphylococcus aureus. Antimicrob Agents Chemother. 2009;53:4172\u20137.","journal-title":"Antimicrob Agents Chemother"},{"key":"836_CR54","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1128\/AAC.32.6.877","volume":"32","author":"LM Bush","year":"1988","unstructured":"Bush LM, Boscia JA, Kaye D. Daptomycin\u00a0(LY146032) treatment of experimental enterococcal endocarditis. Antimicrob Agents Chemother. 1988;32:877\u201381.","journal-title":"Antimicrob Agents Chemother"},{"key":"836_CR55","doi-asserted-by":"crossref","first-page":"2611","DOI":"10.1128\/AAC.36.12.2611","volume":"36","author":"F Caron","year":"1992","unstructured":"Caron F, Kitzis MD, Gutmann L, Cremieux AC, Maziere B, Vallois JM, Saleh-Mghir A, Lemeland JF, Carbon C. Daptomycin\u00a0or teicoplanin in combination with\u00a0gentamicin\u00a0for treatment of experimental endocarditis due to a highly glycopeptide-resistant isolate of Enterococcus\u00a0faecium. Antimicrob Agents Chemother. 1992;36:2611\u20136.","journal-title":"Antimicrob Agents Chemother"},{"key":"836_CR56","doi-asserted-by":"crossref","first-page":"4612","DOI":"10.1128\/AAC.02790-13","volume":"58","author":"MK Luther","year":"2014","unstructured":"Luther MK, Arvanitis M, Mylonakis E, LaPlante KL. Activity of\u00a0daptomycin\u00a0or linezolid in combination with rifampin or gentamicin against biofilm-forming\u00a0Enterococcus\u00a0faecalis or E. faecium in an in vitro pharmacodynamic model using simulated endocardial vegetations and an in vivo survival assay using Galleria mellonella larvae. Antimicrob Agents Chemother. 2014;58:4612\u201320.","journal-title":"Antimicrob Agents Chemother"},{"key":"836_CR57","doi-asserted-by":"crossref","first-page":"4821","DOI":"10.1128\/AAC.00141-11","volume":"55","author":"U Furustrand Tafin","year":"2011","unstructured":"Furustrand Tafin U, Majic I, Zalila Belkhodja C, Betrisey B, Corvec S, Zimmerli W, Trampuz A. Gentamicin improves the activities of daptomycin and vancomycin against Enterococcus\u00a0faecalis in vitro and in an experimental foreign-body infection model. Antimicrob Agents Chemother. 2011;55:4821\u20137.","journal-title":"Antimicrob Agents Chemother"},{"key":"836_CR58","doi-asserted-by":"crossref","first-page":"3529","DOI":"10.1128\/AAC.00290-06","volume":"50","author":"CA DeRyke","year":"2006","unstructured":"DeRyke CA, Sutherland C, Zhang B, Nicolau DP, Kuti JL. Serum bactericidal activities of high-dose\u00a0daptomycin\u00a0with and without coadministration of\u00a0gentamicin\u00a0against isolates of Staphylococcus aureus and Enterococcus\u00a0species. Antimicrob Agents Chemother. 2006;50:3529\u201334.","journal-title":"Antimicrob Agents Chemother"},{"key":"836_CR59","doi-asserted-by":"crossref","first-page":"5166","DOI":"10.1128\/AAC.49.12.5166-5168.2005","volume":"49","author":"G Pankey","year":"2005","unstructured":"Pankey G, Ashcraft D, Patel N. In vitro synergy of daptomycin plus rifampin against Enterococcus faecium resistant to both linezolid and vancomycin. Antimicrob Agents Chemother. 2005;49:5166\u20138.","journal-title":"Antimicrob Agents Chemother"},{"key":"836_CR60","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.1086\/522656","volume":"45","author":"CA Arias","year":"2007","unstructured":"Arias CA, Torres HA, Singh KV, Panesso D, Moore J, Wanger A, Murray BE. Failure of\u00a0daptomycin\u00a0monotherapy for endocarditis caused by an\u00a0Enterococcus faecium strain with vancomycin-resistant and vancomycin-susceptible subpopulations and evidence of in vivo loss of the vanA gene cluster. Clin Infect Dis. 2007;45:1343\u20136.","journal-title":"Clin Infect Dis"},{"key":"836_CR61","doi-asserted-by":"crossref","first-page":"1134","DOI":"10.1086\/444459","volume":"41","author":"MP Stevens","year":"2005","unstructured":"Stevens MP, Edmond MB. Endocarditis due to vancomycin-resistant enterococci: case report and review of the literature. Clin Infect Dis. 2005;41:1134\u201342.","journal-title":"Clin Infect Dis"},{"key":"836_CR62","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1179\/joc.2008.20.5.577","volume":"20","author":"S Noviello","year":"2008","unstructured":"Noviello S, Ianniello F, Leone S, Fiore M, Esposito S. In vitro activity of\u00a0tigecycline: MICs, MBCs, time-kill curves and post-antibiotic effect. J Chemother. 2008;20:577\u201380.","journal-title":"J Chemother"},{"key":"836_CR63","doi-asserted-by":"crossref","first-page":"3022","DOI":"10.1128\/AAC.44.11.3022-3027.2000","volume":"44","author":"TM Murphy","year":"2000","unstructured":"Murphy TM, Deitz JM, Petersen PJ, Mikels SM, Weiss WJ. Therapeutic efficacy of GAR-936, a novel glycylcycline, in a rat model of experimental\u00a0endocarditis. Antimicrob Agents Chemother. 2000;44:3022\u20137.","journal-title":"Antimicrob Agents Chemother"},{"key":"836_CR64","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1016\/j.ijantimicag.2006.10.017","volume":"29","author":"S Esposito","year":"2007","unstructured":"Esposito S, Leone S. Antimicrobial treatment for Intensive Care Unit (ICU) infections including the role of the infectious disease specialist. Int J Antimicrob Agents. 2007;29:494\u2013500.","journal-title":"Int J Antimicrob Agents"},{"key":"836_CR65","doi-asserted-by":"crossref","first-page":"2108","DOI":"10.1345\/aph.1M324","volume":"43","author":"AC Schutt","year":"2009","unstructured":"Schutt AC, Bohm NM. Multidrug-resistant Enterococcus faecium\u00a0endocarditis\u00a0treated with combination\u00a0tigecycline\u00a0and high-dose daptomycin. Ann Pharmacother. 2009;43:2108\u201312.","journal-title":"Ann Pharmacother"},{"key":"836_CR66","doi-asserted-by":"crossref","first-page":"3392","DOI":"10.1128\/AAC.00646-13","volume":"57","author":"K Pontikis","year":"2013","unstructured":"Pontikis K, Pefanis A, Tsaganos T, Tzepi IM, Carrer DP, Giamarellou H. Efficacy of\u00a0tigecycline\u00a0alone and in combination with gentamicin in the treatment of experimental endocarditis\u00a0due to linezolid-resistant Enterococcus faecium. Antimicrob Agents Chemother. 2013;57:3392\u20134.","journal-title":"Antimicrob Agents Chemother"},{"key":"836_CR67","doi-asserted-by":"crossref","first-page":"1575","DOI":"10.1517\/13543784.2014.965253","volume":"23","author":"M Bassetti","year":"2014","unstructured":"Bassetti M, Righi E. Eravacycline for the treatment of intra-abdominal infections. Expert Opin Investig Drugs. 2014;23:1575\u201384.","journal-title":"Expert Opin Investig Drugs"},{"key":"836_CR68","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1093\/cid\/ciu580","volume":"59","author":"A R\u00edo del","year":"2014","unstructured":"del R\u00edo A, Gasch O, Moreno A, Pe\u00f1a C, Cuquet J, Soy D, Mestres CA, Su\u00e1rez C, Pare JC, Tubau F, Garcia de la M\u00e0ria C, Marco F, Carratal\u00e0 J, Gatell JM, Gudiol F, Mir\u00f3 JM, FOSIMI Investigators. Efficacy\u00a0and\u00a0safety\u00a0of\u00a0fosfomycin\u00a0plus\u00a0imipenem as rescue therapy for complicated bacteremia and endocarditis due to methicillin-resistant Staphylococcus aureus: a multicenter clinical trial. Clin Infect Dis. 2014;59:1105\u201312.","journal-title":"Clin Infect Dis"},{"key":"836_CR69","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1016\/j.diagmicrobio.2013.07.012","volume":"77","author":"HJ Tang","year":"2013","unstructured":"Tang HJ, Chen CC, Zhang CC, Su BA, Li CM, Weng TC, Chiang SR, Ko WC, Chuang YC. In vitro efficacy of\u00a0fosfomycin-based combinations against clinical vancomycin-resistant Enterococcus\u00a0isolates. Diagn Microbiol Infect Dis. 2013;77:254\u20137.","journal-title":"Diagn Microbiol Infect Dis"},{"key":"836_CR70","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/0732-8893(92)90045-U","volume":"15","author":"LB Rice","year":"1992","unstructured":"Rice LB, Eliopoulos CT, Yao JD, Eliopoulos GM, Moellering RC Jr. In vivo activity of the combination of daptomycin and\u00a0fosfomycin\u00a0compared with daptomycin alone against a strain of\u00a0Enterococcus\u00a0faecalis with high-level gentamicin resistance in the rat\u00a0endocarditismodel. Diagn Microbiol Infect Dis. 1992;15:173\u20136.","journal-title":"Diagn Microbiol Infect Dis"},{"key":"836_CR71","doi-asserted-by":"crossref","first-page":"1284","DOI":"10.1128\/AAC.02583-12","volume":"58","author":"A Oliva","year":"2014","unstructured":"Oliva A, Furustrand Tafin U, Maiolo EM, Jeddari S, B\u00e9trisey B, Trampuz A. Activities of\u00a0fosfomycin\u00a0and rifampin on planktonic and adherent\u00a0Enterococcus\u00a0faecalis strains in an experimental foreign-body infection model. Antimicrob Agents Chemother. 2014;58:1284\u201393.","journal-title":"Antimicrob Agents Chemother"},{"key":"836_CR72","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1159\/000330458","volume":"57","author":"C Farina","year":"2011","unstructured":"Farina C, Russello G, Chinello P, Pasticci MB, Raglio A, Ravasio V, Rizzi M, Scarparo C, Vailati F, Suter F, Italian Infective Endocarditis Study Group (SEI). In vitro activity effects of twelve antibiotics alone and in association against twenty-seven Enterococcus\u00a0faecalis strains isolated from Italian patients with infective\u00a0endocarditis: high in vitro synergistic effect of the association ceftriaxone-fosfomycin. Chemotherapy. 2011;57:426\u201333.","journal-title":"Chemotherapy."},{"key":"836_CR73","doi-asserted-by":"crossref","first-page":"5300","DOI":"10.1128\/AAC.00984-09","volume":"53","author":"C Jacqueline","year":"2009","unstructured":"Jacqueline C, Roquilly A, Desessard C, Boutoille D, Broquet A, Le Mabecque V, Amador G, Potel G, Caillon J, Asehnoune K. In vivo activity of a novel anti-methicillin-resistant Staphylococcus aureus cephalosporin, ceftaroline, against vancomycin-susceptible and -resistant\u00a0Enterococcus\u00a0faecalis strains in a rabbit\u00a0endocarditis\u00a0model: a comparative study with\u00a0linezolid\u00a0and vancomycin. Antimicrob Agents Chemother. 2009;53:5300\u20132.","journal-title":"Antimicrob Agents Chemother"},{"key":"836_CR74","doi-asserted-by":"crossref","first-page":"3174","DOI":"10.1128\/AAC.06439-11","volume":"56","author":"AD Hall","year":"2012","unstructured":"Hall AD, Steed ME, Arias CA, Murray BE, Rybak MJ. Evaluation of standard- and high-dose daptomycin versus\u00a0linezolid\u00a0against vancomycin-resistant Enterococcus isolates in an in vitro pharmacokinetic\/pharmacodynamic model with simulated endocardial vegetations. Antimicrob Agents Chemother. 2012;56:3174\u201380.","journal-title":"Antimicrob Agents Chemother"},{"key":"836_CR75","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1086\/345744","volume":"36","author":"MC Birmingham","year":"2003","unstructured":"Birmingham MC, Rayner CR, Meagher AK, Flavin SM, Batts DH, Schentag JJ. Linezolid for the treatment of multidrug-resistant, gram-positive infections: experience from a compassionate-use program. Clin Infect Dis. 2003;36:159\u201368.","journal-title":"Clin Infect Dis"},{"key":"836_CR76","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1086\/375877","volume":"37","author":"SM Zimmer","year":"2003","unstructured":"Zimmer SM, Caliendo AM, Thigpen MC, Somani J. Failure of\u00a0linezolid\u00a0treatment for enterococcal\u00a0endocarditis. Clin Infect Dis. 2003;37:29\u201330.","journal-title":"Clin Infect Dis"},{"key":"836_CR77","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1128\/AAC.01289-13","volume":"58","author":"EP Balli","year":"2014","unstructured":"Balli EP, Venetis CA, Miyakis S. Systematic review and meta-analysis of linezolid versus daptomycin for treatment of vancomycin-resistant enterococcal bacteremia. Antimicrob Agents Chemother. 2014;58:734\u20139.","journal-title":"Antimicrob Agents Chemother"},{"key":"836_CR78","doi-asserted-by":"crossref","first-page":"5013","DOI":"10.1128\/AAC.00714-13","volume":"57","author":"DW Whang","year":"2013","unstructured":"Whang DW, Miller LG, Partain NM, McKinnell JA. Systematic review and meta-analysis of linezolid and daptomycin for treatment of vancomycin-resistant enterococcal bloodstream infections. Antimicrob Agents Chemother. 2013;57:5013\u20138.","journal-title":"Antimicrob Agents Chemother"},{"key":"836_CR79","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1093\/cid\/civ444","volume":"61","author":"NS Britt","year":"2015","unstructured":"Britt NS, Potter EM, Patel N, Steed ME. Comparison of the effectiveness and safety of linezolid and daptomycin in vancomycin-resistant enterococcal bloodstream infection: a national cohort study of veterans affairs patients. Clin Infect Dis. 2015;61:871\u20138.","journal-title":"Clin Infect Dis"},{"issue":"1","key":"836_CR80","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/j.ijantimicag.2014.03.008","volume":"44","author":"A Holmberg","year":"2014","unstructured":"Holmberg A, Rasmussen M. Antibiotic regimens with rifampicin for treatment of Enterococcus faecium in biofilms. Int J Antimicrob Agents. 2014;44(1):78\u201380.","journal-title":"Int J Antimicrob Agents"},{"key":"836_CR81","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1592\/phco.27.3.476","volume":"27","author":"BC Gebhart","year":"2007","unstructured":"Gebhart BC, Barker BC, Markewitz BA. Decreased serum linezolid levels in a critically ill patient receiving concomitant linezolid and rifampin. Pharmacotherapy. 2007;27:476\u20139.","journal-title":"Pharmacotherapy."},{"key":"836_CR82","doi-asserted-by":"crossref","first-page":"621","DOI":"10.2146\/ajhp130482","volume":"71","author":"JJ Kisgen","year":"2014","unstructured":"Kisgen JJ, Mansour H, Unger NR, Childs LM. Tedizolid: a new oxazolidinone antimicrobial. Am J Health Syst Pharm. 2014;71:621\u201333.","journal-title":"Am J Health Syst Pharm"},{"key":"836_CR83","doi-asserted-by":"crossref","first-page":"1908","DOI":"10.1086\/648438","volume":"49","author":"LD Saravolatz","year":"2009","unstructured":"Saravolatz LD, Stein GE, Johnson LB. Telavancin: a novel lipoglycopeptide. Clin Infect Dis. 2009;49:1908\u201314.","journal-title":"Clin Infect Dis"},{"key":"836_CR84","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1086\/526772","volume":"46","author":"M Billeter","year":"2008","unstructured":"Billeter M, Zervos MJ, Chen AY, Dalovisio JR, Kurukularatne C. Dalbavancin: a Novel Once-Weekly lipoglycopeptide antibiotic. Clin Infect Dis. 2008;46:577\u201383.","journal-title":"Clin Infect Dis"},{"key":"836_CR85","doi-asserted-by":"crossref","first-page":"1639","DOI":"10.1128\/AAC.06067-11","volume":"56","author":"RE Mendes","year":"2012","unstructured":"Mendes RE, Woosley LN, Farrell DJ, Sader HS, Jones RN. Oritavancin\u00a0activity\u00a0against\u00a0vancomycin-susceptible\u00a0and vancomycin-resistant Enterococci with molecularly characterized glycopeptide resistance genes recovered from bacteremic patients, 2009-2010. Antimicrob Agents Chemother. 2012;56:1639\u201342.","journal-title":"Antimicrob Agents Chemother"},{"key":"836_CR86","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1093\/jac\/43.suppl_1.115","volume":"43","author":"A Saleh-Mghir","year":"1999","unstructured":"Saleh-Mghir A, Lefort A, Petegnief Y, Dautrey S, Vallois JM, Le Guludec D, Carbon C, Fantin B. Activity and diffusion of LY333328 in experimental\u00a0endocarditis\u00a0due to vancomycin-resistant Enterococcus faecalis. Antimicrob Agents Chemother. 1999;43:115\u201320.","journal-title":"Antimicrob Agents Chemother"},{"key":"836_CR87","doi-asserted-by":"crossref","first-page":"3017","DOI":"10.1128\/AAC.44.11.3017-3021.2000","volume":"44","author":"A Lefort","year":"2000","unstructured":"Lefort A, Saleh-Mghir A, Garry L, Carbon C, Fantin B. Activity of LY333328 combined with gentamicin in vitro and in rabbit experimental\u00a0endocarditis\u00a0due to vancomycin-susceptible or -resistant Enterococcus faecalis. Antimicrob Agents Chemother. 2000;44:3017\u201321.","journal-title":"Antimicrob Agents Chemother"}],"container-title":["Infection"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s15010-015-0836-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s15010-015-0836-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s15010-015-0836-0","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,5,21]],"date-time":"2022-05-21T04:18:43Z","timestamp":1653106723000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s15010-015-0836-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,9,1]]},"references-count":87,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2016,6]]}},"alternative-id":["836"],"URL":"https:\/\/doi.org\/10.1007\/s15010-015-0836-0","relation":{},"ISSN":["0300-8126","1439-0973"],"issn-type":[{"value":"0300-8126","type":"print"},{"value":"1439-0973","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,9,1]]}}}